| abstract |
REFERS TO SYNTHESIS POLYSACCHARIDES IN ACID FORM, USING FROM 0.1 mg TO 100 mg. PREFERRED COMPOUNDS ARE: METHYL-O- (2,3,4,6-TETRA-O-SULFO-OD-GLUCOPYRANOSIL) - (1 4) -O- (2,3,6-TRI-O-SULFO-OD- GLUCOPYRANOSIL) - (1 4) -O- (2,3,6-TRI-O-SULFO-ß-D-GLUCOPYRANOSIL) - (1 4) -O- (2,3-DI-O-METHYL-6- O-SULFO-OD-GLUCOPYRANOSIL) - (1 4) -O- (2,3,6-TRI-O-METHYL-ß-D-GLUCOPYRANOSIL) - (1 4) - [O- (2,3,6 -TRI-O-METHYL-OD-GLUCOPYRANOSIL) - (1 4) -O- (2,3,6-TRI-O-METHYL-ß-D-GLUCOPYRANOSIL) - (1 4)] 3-O- (2 , 3-DI-O-METHYL-6-O-SULFO-OD-GLUCOPYRANOSIL) - (1 4) -O- (ACID-2,3-DI-O-METHYL-ß-D-GLUCOPYRANOSYLURONIC) - (1 4 ) -O- (2,3,6-TRI-O-SULFO-OD-GLUCOPYRANOSIL) - (1 4) -O-ACID-2,3-DI-O-METHYL-OL-IDOPYRANOSYLURONIC) - (1 4) -3-O-METHYL-2,6-DI-O-SULFO-OD-GLUCOPYRANOSIDE. POLYSACCHARIDE ACTS AS AN ANTICOAGULANT AND ANTI-THROMBOTIC OF HEPARIN AND MAY BE USEFUL FOR THE TREATMENT AND PREVENTION OF DISORDERS OF THE CARDIOVASCULAR AND CEREBROVASCULAR SYSTEM, THROMBOEMBOLIC DISORDERS ASSOCIATED WITH AN INFLUENZA RISIABOLIS, ATEROSCLEROSCLEROS |